Congenital Diaphragmatic Hernia (CDH) is a life-threatening congenital anomaly characterized by a diaphragmatic defect, leading to the herniation of abdominal viscera into thorax1,2. This physical compression severely impairs lung development, resulting in pulmonary hypoplasia and persistent pulmonary hypertension (PPHN), which are the primary drivers of morbidity and mortality. In addition to pulmonary hypoplasia and vascular underdevelopment, impaired cardiac development and ventricular dysfunction have also been shown to significantly influence clinical outcomes in neonates with CDH. The underlying pathophysiology involves abnormal development of both airways and the pulmonary vascular bed, leading to a reduced number of vessels, increased muscularization of arterioles, and consequently, elevated vascular resistance3,4. Objective and quantitative biomarkers are needed to accurately stratify risk, guide interventions, and monitor treatment response in CDH patients5. One critical aspect of this evaluation is the detailed analysis of the pulmonary vasculature, which can provide insights into the extent of pulmonary hypoplasia and the functional capacity of the lungs. Advances in imaging techniques, particularly computed tomography (CT), have enhanced our ability to visualize and quantify the pulmonary vasculature in great detail6,7.
While postnatal Computed Tomography (CT) provides high-resolution anatomical detail of the lungs, analysis of the intricate pulmonary vascular tree remains challenging. Existing methods for vascular segmentation often rely on traditional image processing techniques that require significant manual intervention, are susceptible to image artifacts, and may not be robust to the severe anatomical distortions in CDH7,8,9,10. Deep learning, particularly convolutional neural networks (CNNs) such as the U-Net architecture, has achieved remarkable success in automated medical image segmentation. However, many existing models are trained on healthy subjects or on other disease contexts, limiting their applicability to congenital anomalies such as CDH10,11,12,13.
Despite these advancements, there remain significant gaps in the literature. Many studies have focused on healthy individuals or specific pulmonary conditions, with limited attention to congenital anomalies like CDH12. Additionally, while deep learning models have shown improved performance, they often require large, annotated datasets for training, which are not always available for rare conditions such as CDH. Furthermore, existing models have not fully addressed the challenge of distinguishing between different types of pulmonary vessels (e.g., arteries and veins) in the presence of severe anatomical distortions caused by CDH. This limitation underscores the need for further research to develop more robust models that can accurately segment and analyze the pulmonary vasculature in CDH patients.
This study aims to address these gaps by developing and validating a fully automated deep learning framework to segment the pulmonary vasculature and extract quantitative morphometric features from CT scans. A key innovation of our approach is training our model on a combined dataset of CDH and control patients, enabling it to learn a robust representation of both normal and pathological vascular patterns. While CT imaging involves ionizing radiation, making it unsuitable for routine longitudinal screening, this study serves as a crucial proof-of-concept. The primary goal of this study is to establish that automated radiological quantification of vascular structure is feasible and can reliably differentiate CDH patients from controls. Success in this domain provides the necessary validation to adapt this quantitative framework to radiation-free imaging modalities, such as Magnetic Resonance Imaging (MRI), for future clinical applications.